Reborna Biosciences
$5.3M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Reborna Biosciences is currently valued at $15.2M as of June 25, 2025. The company has raised a total of $18.5M in funding.
Capital Efficiency
With a capital efficiency ratio of 0.82x, Reborna Biosciences has achieved a valuation that is 0.82 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
Reborna Biosciences's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Reborna Biosciences Worth in 2025?
As of 2025, Reborna Biosciences is valued at $15.2M, based on the company's Later Stage VC funding round in June 25, 2025. This valuation positions Reborna Biosciences as one of the leading private companies in the sector.
Reborna Biosciences Valuation History
Reborna Biosciences's funding history demonstrates steady growth and investor confidence.
How Reborna Biosciences Valuation is Determined
Private company valuations like Reborna Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Reborna Biosciences Valuation FAQs
Is Reborna Biosciences profitable?
Reborna Biosciences has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Reborna Biosciences's valuation compare to competitors?
Reborna Biosciences is valued at $15.2M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Reborna Biosciences IPO?
Reborna Biosciences has not announced plans for an initial public offering. Until an IPO, investors can access Reborna Biosciences shares through secondary market platforms.